Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epinephrine in Pterygopalatine Ganglion Block for FESS
NCT03970655Phase 2Completed
- Sponsor
- University of Florida
- Start
- Sep 2019
- Primary completion
- Jan 2026
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of epinephrine in chronic rhinosinusitis (CRS), sponsored by University of Florida. Started Sep 2019; status: completed.
02
Drugs
epinephrine
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on NCT03970655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03970655.